Opoku, Y.K. et al. 2020. Fibroblast Growth Factor–21 ameliorates hepatic encephalopathy by activating the STAT3-SOCS3 pathway to inhibit activated hepatic stellate cells. EXCLI Journal. 19, (May 2020), 567–581. DOI:https://doi.org/10.17179/excli2020-1287.